2877 Share Price

Open 8.42 Change Price %
High 8.50 1 Day 0.06 0.71
Low 8.36 1 Week -0.28 -3.20
Close 8.48 1 Month -0.44 -4.93
Volume 738000 1 Year -0.89 -9.50
52 Week High 9.54
52 Week Low 7.60
2877 Important Levels
Resistance 2 8.61
Resistance 1 8.56
Pivot 8.45
Support 1 8.40
Support 2 8.35
HKG HongKong Most Active Stocks
0997 0.07 16.67%
0136 0.20 5.26%
0261 0.01 0.00%
0566 3.91 0.00%
3988 3.93 -1.01%
0939 6.36 -0.78%
0061 0.03 0.00%
1398 5.08 -1.17%
0493 1.07 -5.31%
3823 0.18 5.88%
More..
HKG HongKong Top Gainers Stocks
8292 0.62 34.78%
8230 0.53 23.26%
0997 0.07 16.67%
0426 1.53 15.91%
0163 2.50 14.68%
0231 0.09 12.50%
0704 0.20 11.11%
0275 0.20 11.11%
8032 0.82 10.81%
0701 0.64 10.34%
More..
HKG HongKong Top Losers Stocks
4333 60.00 -25.00%
0009 0.30 -21.05%
0030 0.26 -18.75%
0952 1.17 -17.02%
8186 0.36 -16.28%
8002 4.00 -15.97%
0381 0.07 -12.50%
0059 0.99 -12.39%
2668 0.62 -11.43%
0449 0.11 -8.33%
More..

China Shineway Pharma. (HKG: 2877)

2877 Technical Analysis 1.5
As on 27th Feb 2017 2877 Share Price closed @ 8.48 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.40 & Sell for SHORT-TERM with Stoploss of 8.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
2877 Target for February
1st Target up-side 9.2
2nd Target up-side 9.4
3rd Target up-side 9.6
1st Target down-side 8.64
2nd Target down-side 8.44
3rd Target down-side 8.24
2877 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.shineway.com
2877 Address
2877
Luan Cheng
Shijiazhuang, 051430
China
Phone: 86 311 8803 0066
Fax: 86 311 8803 0088
2877 Latest News
Hot Dogs and Sausages Market - Global Industry Analysis, Size, Share, Growth ...   PR Newswire (press release)   - 14th Jan 17
Representatives from Hong Kong's Traditional Chinese Medicine Industry Gather ...   Yahoo Finance   - 30th Dec 16
Global Soft Gelatin Capsules Market 2016- Catalent, Aenova, NBTY, Procaps ...   Invest Daily News: Market Research News by Market.Biz (press release)   - 22nd Nov 16
Hot Dogs and Sausages Market is Estimated to be Worth US$80.4 Billion by 2021 ...   PR Newswire (press release)   - 08th Aug 16
Chinese Pharmaceuticals Market: Trends, Reforms, Opportunities and Revenue ...   PR Newswire UK (press release)   - 26th Aug 15
The highest-paid and best-performing CEOs in China   Human Resources Online   - 22nd Jul 15
China's Record 400 Billionaires And Billionaire Families (Full List)   Forbes   - 21st Apr 15
Global and China High Barrier Material (PVDC, EVOH, PEN) Industry Report, 2014 ...   PR Newswire (press release)   - 11th Mar 15
China's largest meat producer Shuanghui to buy Smithfield Foods for $7.1 bn   domain-B   - 29th May 13
China hush as premier's son nears $1bn target   Financial Times   - 27th Jan 10
Interactive Technical Analysis Chart China Shineway Pharma. ( 2877 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on China Shineway Pharma.
2877 Business Profile
China Shineway Pharmaceutical Group Limited, an investment holding company, is engaged in the research, development, manufacture, and trading of prescription and OTC Chinese medicine injections, soft capsules, and granules in the People’s Republic of China and Hong Kong. Its principal products comprise Qing Kai Ling injection used as an anti-viral medicine for the treatment of viral diseases, including respiratory tract infection, viral hepatitis, cerebral haemorrhage, and cerebral thrombosis; Shen Mai injection for the treatment of coronary heart diseases, viral myocarditis, and pulmonary heart diseases; Shu Xie Ning injection for the treatment of cardio-cerebrovascular diseases; and Wu Fu Xin Nao Qing soft capsule for the prevention and treatment of coronary heart diseases and cerebral arteriosclerosis. The company’s products also include Huo Xiang Zheng Qi soft capsule for the prevention and treatment of heat stroke, stomachache, nausea and diarrhoea, and acclimatization sickness; and Pediatric Qing Fei Hua Tan granule for children infected by respiratory related diseases. In addition, it offers Huang Qi injection for the treatment of viral myocarditis, heart malfunction, and hepatitis; Qing Kai Ling soft capsules for the treatment of high fever, viral influenza, and respiratory tract infections; Huamoyan granule for the treatment of acute and chronic synovitis, as well as for after joints surgery treatment; Shujin Tongluo granule for the treatment of spondylosis and neck stiffness, as well as for symptoms comprising neck, shoulder, and back pains; and Jiangzhi Tongluo soft capsules for the treatment of symptoms, such as hyperlipidemia, chest and hypochondrium pain, and chest tightness. The company is headquartered in Shijiazhuang, the People’s Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.